Abeona Therapeutics Files 2024 10-K
Ticker: ABEO · Form: 10-K · Filed: Mar 20, 2025 · CIK: 318306
| Field | Detail |
|---|---|
| Company | Abeona Therapeutics Inc. (ABEO) |
| Form Type | 10-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
ABEO filed its 2024 10-K. Full financials and biz details out now.
AI Summary
Abeona Therapeutics Inc. filed its 2024 10-K on March 20, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Access Pharmaceuticals Inc., is focused on pharmaceutical preparations. Key financial data and operational details for the fiscal year 2024 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Abeona Therapeutics' financial performance and business operations for the fiscal year 2024, including critical details about its financial health and strategic direction.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Abeona Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in their 10-K filing.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (Indicates the end of the reporting period)
- 20250320 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- ABEONA THERAPEUTICS INC. (company) — Filer
- 20241231 (date) — Fiscal Year End
- 20250320 (date) — Filing Date
- ACCESS PHARMACEUTICALS INC (company) — Former Company Name
FAQ
What is Abeona Therapeutics Inc.'s primary business classification?
Abeona Therapeutics Inc. is classified under Pharmaceutical Preparations [2834].
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on March 20, 2025.
What fiscal year does this 10-K report cover?
This 10-K reports on the fiscal year ending December 31, 2024.
What were some of Abeona Therapeutics' former company names?
Abeona Therapeutics Inc. was formerly known as Access Pharmaceuticals Inc. and Chemex Pharmaceuticals Inc.
What is Abeona Therapeutics Inc.'s state of incorporation?
Abeona Therapeutics Inc. is incorporated in Delaware (DE).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 20, 2025 regarding ABEONA THERAPEUTICS INC. (ABEO).